Back to VOLORIDGE INVESTMENT MANAGEMENT, LLC VOLORIDGE INVESTMENT MANAGEMENT, LLC

KNSAKNSA
Showing 8 of 9 quarters

Position history for VOLORIDGE INVESTMENT MANAGEMENT, LLCVOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in KINIKSA PHARMACEUTICALS INTL

No. Voloridge Investment Management exited its KNSA (Kiniksa Pharmaceuticals International) position in Q2 2026. Its Q1 2026 13F listed 134,516 shares worth $6.5M. Voloridge Investment Management already held KNSA in its Q2 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.7M

Total Shares Change

-189,986

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$63.95
0
2026-Q1
Decreased
134,516
-41.2%
$6.5M0.0%$48.15
0
2025-Q4
Decreased
228,933
-23.3%
$9.4M0.0%$41.25
0
2025-Q3
Decreased
298,347
-10.7%
$11.6M0.0%$38.83
0
2025-Q2
Increased
333,923
+412.9%
$9.2M0.0%$27.67
45
2025-Q1
Decreased
65,110
-53.8%
$1.4M0.0%$22.21
0
2024-Q4
Decreased
140,878
-25.9%
$2.8M0.0%$19.78
0
2024-Q3
Increased
189,986
+636.8%
$4.7M0.0%$24.99
43

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used